Evidence map›Paper›PMID 33507375›Full record

SynthesisArchives of orthopaedic and trauma surgery2021

Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: a meta-analysis and review of RCTs.

Pan Jiang, Lianghao Mao, Longwei Qiao, Xuan Lei, Qiping Zheng, Dapeng Li

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Archives of orthopaedic and trauma surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05660824 (Effectiveness of Stromal Vascular Fraction), which is not on this map. Cited by 18 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 6 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05660824 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study : (SPOST Study)

TypeinterventionalSponsorAdrien SchwitzguebelRan2025 to 2027Enrolled108ConditionsOsteoarthritisArmsStromal Vascular Fraction infiltration, Plattelet Rich Plasma infiltration
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 6 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Stem cell injections for osteoarthritis of the knee.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Co-Culture Approaches in Cartilage and Bone Tissue Regeneration.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Infiltration therapy in the context of cartilage surgery.Archives of orthopaedic and trauma surgery · 2024
    Review
  12. Joint interventions in osteoarthritis.Skeletal radiology · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pan Jiang *Affiliated Hospital of Jiangsu University, No.438, Jiefang road, Zhenjiang, 212000, China.
Lianghao Mao *Affiliated Hospital of Jiangsu University, No.438, Jiefang road, Zhenjiang, 212000, China.
Longwei QiaoThe Affiliated Suzhou Hospital of Nanjing Medical University, Nanjing, China.
Xuan LeiAffiliated Hospital of Jiangsu University, No.438, Jiefang road, Zhenjiang, 212000, China.
Qiping ZhengSchool of Medicine, Jiangsu University, Zhenjiang, China.
Dapeng LiAffiliated Hospital of Jiangsu University, No.438, Jiefang road, Zhenjiang, 212000, China. groupresearch0423@hotmail.com.ORCID http://orcid.org/0000-0001-9750-4683
Jiangsu University · CNNanjing Medical University · CN

Funding

The eighteenth batch of scientific research projects of Jiangsu University 18A509Youth Medical Key Talent Project of Jiangsu QNRC2016844
6 · The paper itself

Abstract

introductionOsteoarthritis (OA), which has a high incidence in the elderly, brings a huge economic burden to society. MSCs (Mesenchymal Stem Cells) have shown great multidirectional differentiation potential which are expected to treat OA, and numerous clinical trials have been conducted. However, the efficacy and safety of the MSCs still need to be further integrated and analyzed. MATERIALS AND

methodsWe searched several databases (PubMed, EMBASE, Scopus, Web of Science, Cochrane Library, Ovid, and ScienceDirect) for assessing eligible trials that randomized controlled trials, hyaluronic acid as control, and MSCs injection to treat OA. Vitro studies and animal studies were excluded. Search terms were: "cartilage," "clinical trial," "mesenchymal," "stromal" and "stem cell", "osteoarthritis". The preliminary guidelines and study protocol were published online at PROSPERO.

resultsMany assessment scales could not be improved significantly after 6 months. However, most of the scales were significantly improved after 12 months, indicating that compared with hyaluronic acid, stem cells could relieve OA symptoms significantly. No serious adverse effect was found.

conclusionThere are significant therapeutic effects on joint function, symptoms, and no permanent adverse effect has been found after stem cell treatment. It is promising to apply intro-articular injection of stem cells for OA to clinical application. More researches are needed to supplement present deficiencies.

Indexed as

Mesenchymal Stem Cell TransplantationHumansOsteoarthritis, KneeRandomized Controlled Trials as TopicTreatment OutcomeAdverse effectsMesenchymal stem cellsOsteoarthritisTherapy

Identifiers

PMID33507375
OpenAlexW3125799103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.